Lexology June 5, 2024
DLA Piper

Welcome to FDA Regulatory News and Trends, designed to help you identify significant legal developments and navigate the evolving business, legal, and regulatory world.

CDRH finalizes guidance addressing device remanufacturing and servicing.

  • On May 9, 2024, the FDA Center for Devices and Radiological Health (CDRH) released a guidance document entitled, “Remanufacturing of Medical Devices.” This guidance aims to distinguish the types of activities that qualify as servicing rather than remanufacturing (which involves additional regulatory responsibilities).
  • FDA defines remanufacture as follows: “Process, condition, renovate, repackage, restore, or any other act done to a finished device that significantly changes the finished device’s performance or safety specifications, or intended use.” Since these remanufacturing activities significantly change the device’s performance or safety specifications,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Project Optimus: The evolution of dose optimisation in oncology
Califf: Do right by AI and patients

Share This Article